Clinic, CWRU among Ohio sites participating in study to slow brain changes leading to Alzheimer's
While the AHEAD study has been investigating this second use for lecanemab for several years, the drug made news recently when it received the FDA’s accelerated approval as a treatment for some Alzheimer’s patients.